首页> 外文期刊>Journal of hepato-biliary-pancreatic sciences >Percutaneous transhepatic gallbladder drainage followed by elective laparoscopic cholecystectomy in patients with moderate acute cholecystitis under antithrombotic therapy
【24h】

Percutaneous transhepatic gallbladder drainage followed by elective laparoscopic cholecystectomy in patients with moderate acute cholecystitis under antithrombotic therapy

机译:中度急性胆囊炎患者经抗栓治疗经皮肝穿刺胆囊引流术后择期腹腔镜胆囊切除术

获取原文
获取原文并翻译 | 示例
           

摘要

Background Standard treatment for acute cholecystitis (AC) in patients receiving antithrombotic drugs has not been established. We evaluated the safety of percutaneous transhepatic gallbladder drainage (PTGBD) followed by elective laparoscopic cholecystectomy (LC) in patients with moderate AC who were receiving antithrombotics. Methods Seventy-five patients received PTGBD from January 2006 to March 2013 followed by elective LC for moderate AC. Patients were divided into Group A, which consisted of patients receiving antithrombotic therapy (n = 23), and Group B, which included the remaining patients (n = 52). We analyzed clinical outcomes and perioperative complications between groups. Results No hemorrhagic events occurred during PTGBD insertion regardless of antithrombotic treatment. The open conversion rate was not significantly different between the two groups. Postoperative complications were found in 10 patients (13.3%). The rate of postoperative complications in Group A was slightly higher than that in Group B, but the difference was not significant (21.7% vs. 9.6%; P = 0.15). Complications associated with PTGBD occurred in six patients (8%). There were no significant differences in the incidence of these complications, operation time, intraoperative blood loss, or length of postoperative hospital stay. Conclusions Percutaneous transhepatic gallbladder drainage followed by elective LC may be an effective therapeutic strategy for moderate AC in patients receiving antithrombotic therapy.
机译:背景技术尚未建立接受抗血栓药物治疗的急性胆囊炎(AC)的标准治疗方法。我们评估了接受抗栓剂治疗的中度AC患者经皮肝穿刺胆囊引流(PTGBD)选择性腹腔镜胆囊切除术(LC)的安全性。方法2006年1月至2013年3月,有75例患者接受了PTGBD治疗,随后接受中度AC的选择性LC治疗。患者分为A组(包括接受抗血栓治疗的患者(n = 23))和B组(包括其余患者)(n = 52)。我们分析了两组之间的临床结局和围手术期并发症。结果无论采用何种抗栓治疗,PTGBD插入期间均未发生出血事件。两组之间的开放转化率没有显着差异。 10例(13.3%)被发现有术后并发症。 A组的术后并发症发生率略高于B组,但差异不显着(21.7%对9.6%; P = 0.15)。与PTGBD相关的并发症发生在6名患者中(8%)。这些并发症的发生率,手术时间,术中失血量或术后住院时间无明显差异。结论经皮肝穿刺胆囊引流后行选择性LC可能是接受抗栓治疗的中度AC的有效治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号